Wednesday, June 29, 2011

Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues

Generic Growth Strategies – Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
GBI Research has released its latest research “Lifestyle Disorders Market to 2016 – Limited Pipeline Products and Slow Progress in R&D are Major Concerns”, which essentially provides insights on lifestyle disorders therapeutics sales and price forecasts until 2016. The report also examines the global lifestyle disorders therapies treatment usage patterns. 
In addition, the geographical distribution of lifestyle disorders therapies across the US, the top five countries in the European region and Japan are also provided in the report. The report also includes insights into the lifestyle disorders Research and Development (R&D) pipeline and the potential future blockbusters up to 2016. The report provides an in-depth analysis of the top five lifestyle disorders therapeutic indications, which are erectile dysfunction, obesity, alopecia, smoking cessation and alcohol dependence. Furthermore, it also includes the market forecasts and treatment usage patterns of these four therapeutic indications. The report also explores the competitive landscape including top companies benchmarking. Finally, the key trend analysis on Mergers and Acquisitions (M&As) and licensing agreements involving lifestyle disorders therapies is also presented.It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.GBI Research’s analysis showed that the global lifestyle disorders therapeutics market was segmented into five indications namely erectile dysfunction with the market size of $3.2 billion in 2009, followed by obesity, alopecia, smoking cessation and finally the alcohol dependence market.

ScopeThe scope of this report includes -
  • Annualized market data for the lifestyle disorders therapeutics market from 2001 to 2009, with forecasts to 2016.
  • Market analysis for the five major indications in the global lifestyle disorders therapeutics market which includes Erectile dysfunction, Obesity, Alopecia, Smoking Cessation and Alcohol dependence.
  • Data and analysis on the lifestyle disorders therapeutics market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
  • Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.
  • The competitive landscape of the global lifestyle disorders therapeutics market
  • Key M&A activities and licensing agreements that took place from 2004 to 2010 in the lifestyle disorders therapeutics market.
  • Reasons to buyThe report will enhance your decision making capability. It will allow you to -
  • Build effective strategies to launch their pipeline products by identifying potential geographies.
  • Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
  • Develop key strategic initiatives by studying the key strategies of top competitors.
  • Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
  • Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

Related Reports:
About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
7557 Rambler road,
Tel: +1-888-989-8004